Overview of Controlled Release Mechanisms

Chapter
Part of the Advances in Delivery Science and Technology book series (ADST)

Abstract

Controlled release systems have been developed to improve the temporal and spatial presentation of drug in the body, to protect drug from physiological degradation or elimination, to improve patient compliance, and to enhance quality control in manufacturing of drug products. When designing controlled-release systems, it is important to identify and understand particular mechanisms involved in the release process. Often, more than one mechanism is involved at a given time or different mechanisms may dominate at different stages of the drug delivery process. This chapter begins with several vignettes, each highlighting a mode of controlled drug delivery and identifying associated mechanisms. An introductory description of several of the mechanisms follows. Details regarding these mechanisms are provided in subsequent chapters.

Keywords

Permeability Hydrolysis Convection Retina Polypeptide 

References

  1. 1.
    Amidon GL, Lee PI, Topp EM (eds) (2000) Transport processes in pharmaceutical systems. Marcel Dekker, New YorkGoogle Scholar
  2. 2.
    Amiji M (ed) (2005) Polymeric gene delivery. CRC, Boca Raton, FLGoogle Scholar
  3. 3.
    Arshady R (ed) (2003) Biodegradable polymers. Citus Ltd, LondonGoogle Scholar
  4. 4.
    Baker RW (1987) Controlled release of biologically active agents. Wiley, New YorkGoogle Scholar
  5. 5.
    Chasin M, Langer R (eds) (1990) Biodegradable polymers as drug delivery systems. Marcel Dekker, New YorkGoogle Scholar
  6. 6.
    Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63(3):136–151PubMedCrossRefGoogle Scholar
  7. 7.
    Flynn GL, Yalkowski SH, Roseman TJ (1974) Mass transfer phenomena and models: theoretical concepts. J Pharm Sci 63:479–510PubMedCrossRefGoogle Scholar
  8. 8.
    Friend DR (ed) (1992) Oral colon specific drug delivery. CRC, Boca Raton, FLGoogle Scholar
  9. 9.
    Grassi M, Grassi G, Lapasin R, Colombo I (eds) (2007) Understanding drug release and absorption mechanisms. CRC, Boca Raton, FLGoogle Scholar
  10. 10.
    Guy RH, Hadgraft J (eds) (2003) Transdermal drug delivery systems: second edition, revised and expanded. Marcel Dekker, New YorkGoogle Scholar
  11. 11.
    Hillery AM, Lloyd AW, Swarbrick J (2001) Drug delivery and targeting for pharmacists and pharmaceutical scientists. Taylor & Francis, OxfordGoogle Scholar
  12. 12.
    Kim C-J (1999) Controlled release dosage form design. Technomic, Lancaster, PAGoogle Scholar
  13. 13.
    Kydonieus A (ed) (1993) Treatise on controlled release. Marcel Dekker, New YorkGoogle Scholar
  14. 14.
    Langer R (1990) New methods in drug delivery. Science 249:1527–1533PubMedCrossRefGoogle Scholar
  15. 15.
    Langer R (1998) Drug delivery and targeting. Nature 392:5–10PubMedGoogle Scholar
  16. 16.
    Langer R, Peppas NA (1981) Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2:201–214PubMedCrossRefGoogle Scholar
  17. 17.
    Langer R, Peppas NA (2003) Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J 49:2990–3006CrossRefGoogle Scholar
  18. 18.
    Lee VHL (ed) (1991) Peptide and protein drug delivery. CRC, Boca Raton, FLGoogle Scholar
  19. 19.
    Mahato R (ed) (2005) Biomaterials for delivery and targeting of proteins and nucleic acids. CRC, Boca Raton, FLGoogle Scholar
  20. 20.
    Mathiowitz E (ed) (1999) Encyclopedia of controlled drug delivery. Wiley, New YorkGoogle Scholar
  21. 21.
    Mathiowitz E, Chickering DE, Lehr C-M (eds) (1999) Bioadhesive drug delivery systems. Marcel Dekker, New YorkGoogle Scholar
  22. 22.
    Mitra AK (ed) (2003) Ophthalmic drug delivery systems. Marcel Dekker, New YorkGoogle Scholar
  23. 23.
    Ottenbrite R, Kim SW (eds) (2001) Polymeric drugs and drug delivery systems. CRC, Boca Raton, FLGoogle Scholar
  24. 24.
    Park K (ed) (1997) Controlled drug delivery. Challenges and strategies. American Chemical Society, Washington, DCGoogle Scholar
  25. 25.
    Park K, Shalaby WSW, Park K (1993) Biodegradable hydrogels for drug delivery. Technomic, Lancaster, PAGoogle Scholar
  26. 26.
    Peppas NA (ed) (1987) Hydrogels in medicine and pharmacy. CRC, Boca Raton, PAGoogle Scholar
  27. 27.
    Peppas NA, Hilt JZ, Khademhosseini A, Langer R (2006) Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 18:1345–1380CrossRefGoogle Scholar
  28. 28.
    Ranade VV, Hollinger MA (eds) (2003) Drug delivery systems. CRC, Boca Raton, FLGoogle Scholar
  29. 29.
    Rathbone MJ, Hadgraft J, Roberts MS (eds) (2003) Modified-release drug delivery technology. Marcel Dekker, New YorkGoogle Scholar
  30. 30.
    Saltzman WM (2001) Drug delivery: engineering principles for drug therapy. Oxford University Press, New YorkGoogle Scholar
  31. 31.
    Santini JT, Cima MJ, Langer R (1999) A controlled release microchip. Nature 397:335–338PubMedCrossRefGoogle Scholar
  32. 32.
    Santus G, Baker RW (1995) Osmotic drug delivery: a review of the patent literature. J Contr Rel 35:1–21CrossRefGoogle Scholar
  33. 33.
    Tanquary AC, Lacey RE (eds) (1974) Controlled release of biologically active agents. Plenum, New YorkGoogle Scholar
  34. 34.
    Uchegbu IF, Schatzlein AG (eds) (2008) Polymers in drug delivery. Taylor and Francis, Boca Raton, FLGoogle Scholar
  35. 35.
    Wise DL (ed) (2000) Handbook of pharmaceutical controlled release technology. Marcel Dekker, New YorkGoogle Scholar

Copyright information

© Springer US 2012

Authors and Affiliations

  1. 1.Departments of Pharmaceutics and Biomedical EngineeringUniversity of MinnesotaMinneapolisUSA
  2. 2.Department of Pharmaceutics WDH 9-177University of MinnesotaMinneapolisUSA
  3. 3.School of PharmacyGriffith UniversitySouthportAustralia

Personalised recommendations